Metraipolis › archive › dc_173da158a659
Quaking-induced conversion of prion protein on a thermal mixer accelerates detection in brains infected with transmissible spongiform encephalopathy agents — Europe PMC PMID:31830760
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/31830760
- DOI
- 10.1371/journal.pone.0225904
- License (as archived)
- CC0-1.0
- Archived
- 2026-11-09T22:13:37.375Z
- SHA-256 of the archived text
a46e0c27179462b91bd0a2ea09ecff013836d88f4fbb3efd47b9da5130083f25- Stable URL of this page
https://metraipolis.com/documento/dc_173da158a659
How to cite
Quaking-induced conversion of prion protein on a thermal mixer accelerates detection in brains infected with transmissible spongiform encephalopathy agents — Europe PMC PMID:31830760 — Europe PMC (en), https://europepmc.org/article/MED/31830760 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_173da158a659 (Metraipolis archive dc_173da158a659, sha256 a46e0c27179462b91bd0a2ea09ecff013836d88f4fbb3efd47b9da5130083f25)
BibTeX
@misc{dc173da158a659,
title = {Quaking-induced conversion of prion protein on a thermal mixer accelerates detection in brains infected with transmissible spongiform encephalopathy agents — Europe PMC PMID:31830760},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/31830760},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_173da158a659; sha256 a46e0c27179462b91bd0a2ea09ecff013836d88f4fbb3efd47b9da5130083f25},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/31830760. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Detection of misfolded prion protein, PrPTSE, in biological samples is important to develop antemortem tests for transmissible spongiform encephalopathies (TSEs). The real-time quaking-induced conversion (RT-QuIC) assay detects PrPTSE but requires dedicated equipment and relatively long incubation times when applied to samples containing extremely low levels of PrPTSE. It was shown that a microplate shaker with heated top (Thermomixer-C) accelerated amplification of PrPTSE in brain suspensions of 263K scrapie and sporadic Creutzfeldt-Jakob disease (sCJD). We expanded the investigation to include TSE agents previously untested, including chronic wasting disease (CWD), macaque-adapted variant CJD (vCJD) and human vCJD, and we further characterized the assays conducted at 42°C and 55°C. PrPTSE from all brains containing the TSE agents were successfully amplified using a truncated hamster recombinant protein except for human vCJD which required truncated bank vole recombinant protein. We compared assays conducted at 42°C on Thermomixer-C, Thermomixer-R (without heated top) and on a fluorimeter used for RT-QuIC. QuIC on Thermomixer-R achieved in only 18 hours assay sensitivity similar to that of RT-QuIC read at 60 hours (or 48 hours with sCJD). QuIC on Thermomixer-C required 24 hours to complete and the endpoint titers of some TSEs were 10-fold lower than those obtained with RT-QuIC and Thermomixer-R. Conversely, at 55°C, the reactions with sCJD and CWD on Thermomixer-C achieved the same sensitivity as with RT-QuIC but in shorter times. Human vCJD samples tested at higher temperatures gave rise to high reactivity in wells containing normal control samples. Similarly, reactions on Thermomixer-R were unsuitable at 55°C. The main disadvantage of Thermomixers is that they cannot track formation of PrP fibrils in real time, a feature useful in some applications. The main advantages of Thermomixers are that they need shorter reaction times to detect PrPTSE, are easier to use, involve more robust equipment, and are relatively affordable. Improvements to QuIC using thermal mixers may help develop accessible antemortem TSE tests. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PloS one, 2019 (prima pubblicazione 2019-12-12). Identificativi: PMID 31830760 · PMCID PMC6908438 · DOI 10.1371/journal.pone.0225904. Pagina: https://europepmc.org/article/MED/31830760 — https://doi.org/10.1371/journal.pone.0225904. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-11-09T22:10:28.441Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.